Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cell Therapeutics, Inc. announced the preliminary results of its separate concurrent fixed price exchange offers for any and all of the approximately $118.9 million outstanding principal amount of five series of its convertible notes. The Exchange Offers expired at New York City time, on Tuesday, June 2009.

Today in Popular Press...keeping you current

A look at how far hospitals have come since To Err is Human report
American Hospital Association News, 11/25/09

AstraZeneca and the Philadelphia Department of Public Health provide free medicines to Pennsylvanias uninsured
AstraZeneca, 11/24/09

Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards
Amgen, 11/24/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address